Arthritis management for dogs in 2026 offers more options than ever, combining traditional and novel approaches for comprehensive pain control.
2026 arthritis management for dogs is better than it has ever been, with multiple effective options across different mechanisms and routes. The availability of Librela for dogs who cannot tolerate NSAIDs eliminates a treatment gap that previously left arthritic dogs without effective pain management. Combined pharmacological and physical therapy approaches provide comprehensive welfare improvement that drug treatment alone cannot achieve.